With expertise in the development of vaccine formulations, VaxForm personnel provide consulting /contract services in the space. With the lead personnel having expertise and the firm the relevant facilities, assistance to others in in development of a vaccine product can includes small scale antigen fermentation and purification, formulation development including adjuvantation and stabilization, as well as filling of final drug product. VaxForm's current R&D program include an Oral SARS-CoV-2 Vaccine; a Oral DTaP Vaccine and a Vaccine targeting Streptococcus pyogenes
